BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Astellas at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Astellas takes part in 3 sessions at BIO-Europe 2026 in Cologne. Its sessions centre on business development, covering how partnering is changing in a shifting global landscape, how life sciences transactions now combine capital, creative structures and optionality, and how biotechs can keep pace with faster pharma dealmaking. Astellas also sponsors the meeting.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
Astellas Tokyo, Japan | ◇Silver Sponsor |
Japanese pharmaceutical company developing medicines in oncology, ophthalmology, urology and immunology. | Panel Mon Nov 9 13:00–14:00 Navigating partnering and business development in a shifting global landscape How funding conditions, treatment trends and geopolitics are shaping partnerships and acquisitions between drug and biotech companies, with real deal examples. Panel Tue Nov 10 16:00–16:45 Capital, Creativity, and Optionality: The New Anatomy of Life Sciences Transactions How biotechs raise money by selling rights to future drug sales, spinning off new companies, or going public by merging with a listed one. Panel Tue Nov 10 14:00–14:25 Faster, Sharper, More Competitive: How Pharma BD Is Evolving and How Biotechs Can Keep Pace How pharma deal teams now screen incoming biotech offers with new tools, and what a well-prepared biotech pitch looks like today. |
Find decision makers at Astellas
Tell us what you sell and we’ll find the people at Astellas most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction